Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v6-EN
Language English English
Date Updated 2022-08-04 2022-06-03
Drug Identification Number 02495937 02495937
Brand name AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
Common or Proper name AMOXI-CLAV AMOXI-CLAV
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients AMOXICILLIN CLAVULANIC ACID AMOXICILLIN CLAVULANIC ACID
Strength(s) 2000MG 200MG 2000MG 200MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10PSOIJ 10PSOIJ
ATC code J01CR J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2022-05-04 2022-05-04
Estimated end date 2022-09-02 2022-09-02
Actual end date 2022-08-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments